Stay Connected
Join us on Facebook Follow us on linked in Follow us on YouTube Follow us on Vimeo
Gastroenterology-GI drug development clinical trial support - Medpace gastroenterology - GI CRO
Gastroenterology Clinical Research
request info
First Name*:
Last Name*:
Company*:
Email*:
Leave a Message:


Please enter the security code


Find out how our medical, regulatory, and operational expertise in gastroenterology clinical development can help with your next GI study or program.


Learn More

Gastroenterology CRO for Clinical Research

With extensive global expertise in the design and medical oversight of gastroenterology clinical trials, Medpace is well-positioned to help our clients develop new and effective treatments for digestive disorders and diseases. Medpace is the gastroenterology CRO that helps our clients:

  • Optimize clinical trial design
  • Proactively assess and meet potential regulatory challenges
  • Standardize patient inclusion and efficacy outcome assessment

Gastroenterology Experience

Experience in all major gastroenterology indications, spanning both adult and pediatric populations.
  • Inflammatory Bowel Disease including:
    • Ulcerative Colitis
    • Crohn's Disease
  • Functional GI Disorders including:
    • Chronic Idiopathic Constipation (also drug-induced constipation)
    • Irritable Bowel Syndrome
    • Postprandial Distress and Gastroparesis (also GERD)
  • Liver Disease including:
    • Viral Hepatitis
    • Nonalcoholic steatohepatitis (NASH)

The Medpace Difference for Gastroenterology Studies

In addition to the Medpace Difference that applies to all of our therapeutic areas, our gastroenterology clients benefit from:

  • Gastroenterology medical expert with a background in both hospital-based clinical practice and pharmaceutical development.
    • Recognized in the field for his contribution to the pioneering work on standardization of central imaging in inflammatory bowel disease drug development.
    • Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom.
  • Centralized imaging services for efficient, cost-effective assessment of efficacy outcomes.
  • Global central laboratories that can help design and execute your protocol testing needs with a strong selection of inflammatory biomarkers and cytokines.